Charles Schwab’s Aceragen Inc ACGN Stock Holding History
Bought
Maintained
Sold
Other funds holding ACGN
VF
HCM
Charles Schwab's ACGN Position: Q2 2021 in Review
Charles Schwab sold out of Aceragen Inc (ACGN) in Q2 2021, closing a stake of 1,086 shares — an estimated $24K sold.
Charles Schwab first reported a position in ACGN in Q2 2014 and held it in 21 quarters. The position peaked at $798K in Q1 2017. 47 funds tracked by Wall St. Rank hold ACGN as of Q2 2021.
- Charles Schwab reported no remaining Aceragen Inc position as of Q2 2021 after selling out during the quarter.
- Charles Schwab sold 1,086 Aceragen Inc shares in Q2 2021, an estimated $24K.
- Charles Schwab first reported a position in Aceragen Inc in Q2 2014 and held it in 21 quarters.
- Charles Schwab's Aceragen Inc position peaked at $798K in Q1 2017.
- 47 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2021.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.